This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Alexion Pharmaceuticals, Inc.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Antonio M Risitano: Innovator in Hemolytic Disorder Treatments
Introduction
Antonio M Risitano is a notable inventor based in Naples, Italy. He has made significant contributions to the field of medicine, particularly in the treatment of hemolytic disorders. His innovative approach has led to advancements that benefit patients suffering from these conditions.
Latest Patents
Antonio M Risitano holds a patent for a method aimed at treating paroxysmal nocturnal hemoglobinuria and other hemolytic anemias. The patent, titled "Methods for treating subjects having complement-mediated hemolytic disorders," focuses on administering a composition that inhibits the activity of the complement alternative pathway. This method provides an effective treatment option for individuals affected by these serious health issues. He has 1 patent to his name.
Career Highlights
Antonio is associated with Alexion Pharmaceuticals, Inc., a company renowned for its focus on innovative therapies for rare diseases. His work at Alexion has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
One of his notable collaborators is V Michael Holers, with whom he has worked closely to advance the understanding and treatment of hemolytic disorders.
Conclusion
Antonio M Risitano's contributions to the treatment of hemolytic disorders highlight his dedication to improving patient outcomes. His innovative methods and collaboration with esteemed colleagues continue to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile